BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38092311)

  • 1. Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B.
    Chua HH; Chen YH; Wu LL; Yang HC; Lin CR; Chen HL; Wu JF; Chang MH; Chen PJ; Ni YH
    Cell Mol Gastroenterol Hepatol; 2024; 17(3):361-381. PubMed ID: 38092311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model.
    Li X; Wu S; Du Y; Yang L; Li Y; Hong B
    Int J Antimicrob Agents; 2020 Jul; 56(1):106000. PubMed ID: 32360229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBV pre-core mutant in genotype-D infected children is selected during HBeAg/anti-HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood.
    Colombatto P; Barbera C; Bortolotti F; Maina AM; Moriconi F; Cavallone D; Calvo P; Oliveri F; Bonino F; Brunetto MR
    J Med Virol; 2018 Jul; 90(7):1232-1239. PubMed ID: 29488227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of pre-core mutant chronic hepatitis B.
    Papatheodoridis GV; Hadziyannis SJ
    J Viral Hepat; 2001 Sep; 8(5):311-21. PubMed ID: 11555188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural history and disease progression of chronic hepatitis B virus infection].
    Wang LJ; Li MW; Liu YN; Chen XM; Zhao JM; Liu SH; Lu FM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):920-926. PubMed ID: 36241234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Bosnak M; Ucmak H; Dagli A; Ece A; Haspolat K
    J Gastroenterol Hepatol; 2003 Feb; 18(2):218-22. PubMed ID: 12542609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.
    Li MH; Lu Y; Zhang L; Wang XY; Ran CP; Hao HX; Zhang D; Qu XJ; Shen G; Wu SL; Cao WH; Qi TL; Liu RY; Hu LP; Chang M; Hua WH; Liu SA; Wan G; Xie Y
    Chin Med J (Engl); 2018 Aug; 131(15):1813-1818. PubMed ID: 30058578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study.
    Hamida ME; Raja SM; Seyoum Y; Elkhidir IM; Tekle F
    BMC Gastroenterol; 2021 May; 21(1):198. PubMed ID: 33933017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.
    Li YN; Kang NL; Jiang JJ; Zhu YY; Liu YR; Zeng DW; Wang F
    World J Gastroenterol; 2022 Sep; 28(35):5188-5202. PubMed ID: 36188719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome.
    Sun Z; Huang C; Shi Y; Wang R; Fan J; Yu Y; Zhang Z; Zhu K; Li M; Ni Q; Chen Z; Zheng M; Yang Z
    Front Med (Lausanne); 2021; 8():708495. PubMed ID: 34671614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.
    Alexopoulou A; Karayiannis P
    World J Gastroenterol; 2014 Jun; 20(24):7644-52. PubMed ID: 24976702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.
    Shen T; Wu WM; Du WH; Wang L; He G; Tan L; Wang Z; Chen R; Hu M; Ren YP
    Lipids Health Dis; 2016 Dec; 15(1):210. PubMed ID: 27927202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Differences Of Red Cell Distribution Width Levels Contribute To The Differential Diagnosis Of Hepatitis B Virus-related Chronic Liver Diseases: A Case-control Study.
    Zhu M; Han M; Xiao X; Lu S; Guan Z; Song Y; Liu C
    Int J Med Sci; 2019; 16(5):720-728. PubMed ID: 31217740
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum HBV RNA levels among untreated adults with chronic hepatitis B in distinct immune phases and liver histopathology statuses.
    Xu Q; Ding H; Bai T; Huang R; Wang J; Zhang J; Luan H; Wang J; Yang Y; Chen Y
    J Mol Histol; 2023 Dec; 54(6):739-749. PubMed ID: 37843699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries.
    Hadziyannis SJ
    J Hepatol; 2011 Jul; 55(1):183-91. PubMed ID: 21238520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8
    Xun Z; Lin J; Yu Q; Liu C; Huang J; Shang H; Guo J; Ye Y; Wu W; Zeng Y; Wu S; Xu S; Chen T; Chen J; Ou Q
    Cell Mol Immunol; 2021 Feb; 18(2):461-471. PubMed ID: 33432062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection.
    Liu Y; Jiang M; Xue J; Yan H; Liang X
    BMC Gastroenterol; 2019 Apr; 19(1):53. PubMed ID: 30991954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.